Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Sell
3,916
-481
-11% -$99.7K 0.01% 772
2026
Q1
$987K Buy
4,397
+156
+4% +$38.9K 0.01% 624
2025
Q4
$1.03M Sell
4,241
-96
-2% -$24.6K 0.01% 585
2025
Q3
$1.19M Buy
4,337
+99
+2% +$27K 0.02% 534
2025
Q2
$1.09M Buy
4,238
+251
+6% +$59.9K 0.02% 562
2025
Q1
$893K Sell
3,987
-23
-0.6% -$5.37K 0.01% 595
2024
Q4
$920K Sell
4,010
-644
-14% -$155K 0.01% 609
2024
Q3
$1.11M Buy
4,654
+917
+25% +$205K 0.02% 533
2024
Q2
$700K Buy
+3,737
New +$758K 0.01% 663

Other funds holding RMD

Choreo LLC's RMD Position: Q2 2026 in Review

Choreo LLC reduced its ResMed (RMD) stake by 11% in Q2 2026, selling an estimated $99.7K and leaving 3,916 shares worth $763K. The position accounts for 0.01% of the portfolio, ranked #772.

Choreo LLC first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.19M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Choreo LLC held 3,916 shares of ResMed worth $763K as of Q2 2026.
  • Choreo LLC sold 481 ResMed shares in Q2 2026, an estimated $99.7K.
  • ResMed made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #772 holding.
  • Choreo LLC first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's ResMed position peaked at $1.19M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.